Business Wire

Investors Signal Strong Demand for Next‑Generation ETF Structures and Expanded Investment Strategies: BBH Investor Services 2026 Global ETF Investor Survey

3.3.2026 15:00:00 CET | Business Wire | Press release

Share

Survey finds 98% of professional investors expect to increase active ETF allocations, while nearly all would consider private markets ETFs

Brown Brothers Harriman (BBH) Investor Services’ 13th annual Global ETF Investor Survey of institutional investors, fund managers, and financial advisors highlights strong enthusiasm for new ETF structures, even as investors refocus on fundamentals to generate alpha amid heightened market volatility. This year’s findings show that 96% of investors plan to increase their ETF allocations over the next 12 months, matching last year’s record‑high level and reinforcing the ETF structure’s central role in portfolios during periods of market uncertainty.

Investors are reshuffling portfolios to accommodate more active ETFs: 53% will reduce index-based ETF allocations, and nearly half will cut index and actively managed mutual funds. With active ETF assets nearing $2 trillion, 94% believe they’ll top $10 trillion within a decade, and 77% expect this milestone in seven years.

“ETF issuers are innovating to meet the evolving needs of today’s investors,” said Tim Huver, Managing Director on the ETF Servicing Team at BBH. “The next phase of ETF product growth will look very different from the prior decade, with greater emphasis on active management, expanded access to new asset classes, and the operational sophistication required to support more complex strategies at scale.”

Appetite for innovation is surging: 82% would consider ETF share classes of mutual funds, while 99% are open to private markets ETFs, signaling demand for broader access and efficiency.

Additional Key Findings

  • 63% plan to work with more ETF issuers.
  • 65% say ETF issuers stand out with superior client service and support.
  • 58% don’t believe tokenization will fundamentally change financial markets.
  • 17% intend to invest in cryptocurrency ETFs, though performance outlooks for crypto assets have dropped sharply since last year.
  • Investors expect increased allocations to dividend/income (33%), sector/thematic (28%), defined outcome (26%), and money market ETFs (20%).
  • Regional trends persist: U.S. leads in ETF adoption, Greater China sees notable growth, and Europe focuses on income, diversification, and risk management amid regulatory shifts.

Industry thought leaders Deborah Fuhr (ETFGI) and Elias Haddad (BBH) provide additional insights on active ETF growth, market trends, and how macroeconomic factors may shape ETF flows in 2026.

The full 2026 Global ETF Investor Survey is available at BBH.com. The survey was conducted by Wakefield Research on behalf of BBH and included 325 professional ETF investors across the U.S., Greater China, and Europe, representing institutional investors, financial advisors, fund management firms, private banks, and wealth management organizations.

About Brown Brothers Harriman (BBH)

Brown Brothers Harriman (BBH) is a global financial services firm known for premium service and specialist expertise. For more than 200 years, BBH has partnered with clients to navigate complexity, innovate with purpose, and succeed in evolving financial markets. Its 6,000 employees serve clients and their investments in more than 90 markets from 18 offices worldwide. As a private partnership, BBH is uniquely structured to put clients first and deliver success that lasts.

BBH Investor Services is a leading provider of asset servicing and operating model solutions to global asset managers and financial institutions. Asset servicing capabilities include custody, global tax services, depositary and trustee services, fund accounting, administration, and transfer agency. Operating model solutions address platform, data, and connectivity challenges across open‑architecture environments, helping clients drive growth, operational efficiency, and resiliency while enhancing reporting and oversight. BBH has been servicing ETFs for over two decades.

References to specific types of securities and asset classes are for informational purposes only and are not intended to be, and should not be interpreted as, investment recommendations.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260303929711/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release

With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f

Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release

Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th

Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release

Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t

Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr

Takeda Announces Positive Topline Results from Pivotal Phase 2/3 Clinical Trial of TAK-881 in Primary Immunodeficiency Disease (PID)4.5.2026 14:00:00 CEST | Press release

Investigational TAK-881 was comparable to established HYQVIA while also demonstrating reduced infusion volume and duration for PID patients Takeda (TSE:4502/NYSE:TAK) today announced that TAK-881-3001, a pivotal Phase 2/3 clinical trial in patients with Primary Immunodeficiency Disease (PID), met its primary endpoint, which demonstrated pharmacokinetic (PK) comparability between the investigational TAK-881 [Immune Globulin Subcutaneous (Human), 20% Solution (SCIG 20%) with Recombinant Human Hyaluronidase] and HYQVIA [Immune Globulin Infusion (Human) 10% with Recombinant Human Hyaluronidase]. Additionally, secondary endpoints showed that TAK-881, a SCIG 20% facilitated with hyaluronidase, demonstrated safety, efficacy and tolerability profiles comparable to HYQVIA, an established SCIG 10% facilitated with hyaluronidase. These findings support the potential of TAK-881 to deliver the required immunoglobulin (IG) dose for PID patients in half the volume of HYQVIA, reducing infusion duratio

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye